CD47型
阿霉素
癌症
化学
癌症研究
癌细胞
免疫系统
吞噬作用
化疗
免疫原性细胞死亡
癌症治疗
免疫
树枝状大分子
癌症治疗
抗癌药
细胞毒性
免疫疗法
常用化疗药物
癌症化疗
抗体
药品
作者
Baoping Lian,Dandan Zhu,Chen Peng,Zhihui Wang,Fanzhen Meng,Ran Yan,Nikolay A. Pyataev,Xiaoxuan Liu
摘要
Restoring antitumor immunity while enhancing the chemotherapy efficacy represents an optimistic strategy for cancer treatment. Enabling macrophage-mediated phagocytosis of cancer cells is pivotal for rehabilitating effective immune responses. However, its efficacy is often limited by elevated anti-phagocytic signals, such as CD47, and insufficient pro-phagocytic signals on cancer cells. We employed a synergic chemo-immunotherapeutic approach involving the chemotherapeutic agent doxorubicin (DOX) together with siRNA targeting CD47 (siCD47), co-delivered by a bola-amphiphilic dendrimer (bola4A) as a nanocarrier. The co-delivery system (bola4A/DOX/siCD47) was established by encapsulating DOX within the hydrophobic interior of dendrimer nanomicelles, while complexing the negatively charged siCD47 to the positively charged dendrimer surface. The bola4A/DOX/siCD47 effectively downregulated CD47 expression and attenuated the CD47-signal regulatory protein α (SIRPα) axis-mediated anti-phagocytic signal. Concurrently, DOX induced immunogenic cell death (ICD) and significantly increased the exposure of calreticulin (CALR), a pro-phagocytic signal that elicits immune response. Consequently, bola4A/DOX/siCD47 enhanced phagocytosis of tumor cells by macrophages and reprogrammed the tumor immunosuppressive microenvironment (TME) towards enhanced macrophage phagocytosis, dendritic cell maturation, T cell infiltration, and elevated secretion of pro-inflammatory cytokines. Altogether, bola4A/DOX/siCD47 exhibited a potent antitumor effect through the coordinated action of DOX with siCD47 and offers a promising approach for synergistic cancer chemo-immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI